- Supply TypeManufacturer, Exporter, Supplier, Retailer
- Preferred Buyer Location All over the world
For active immunization against invasive meningococcal disease caused by meningococcus group A only.Children from 12 months of age, adolescents and adults up to 29 years of age should receive a single 0.5 ml dose.